Job Description: Business Overview Rakuten Group offers a diverse range of services, including e-commerce, fintech, mobile, travel, and entertainment. Leveraging customer touchpoints, Rakuten IDs, purchase data, point programs, and media assets cultivated through these services, we
Entity: Customers & Products Job Family Group: Sales Group Job Description: The role entails designing, maintaining and developing the strategic relationship with partner OEMs in Japan and the global business development pipeline for J-OEMs by identifying
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Job Summary: JOB DESCRIPTION – EVENT PROGRAMMER Location: Tokyo, Japan Division: Ticketmaster APAC Line Manager: Director of Operations Contract Terms: Permanent, Full Time THE TEAM Global Field Support & Operations organization has the mission to build
Responsibilities Develop and execute business plans for battery sales through battery specialist, wholesaler, and retail chain channels in close cooperation with cross functional teams. Forecast sales, develop strategies/models and evaluate their effectiveness. Deep understanding of products
Job Description - Lead Solutions Engineer The Lead Solutions Engineer Engineer is a technical expert trusted advisor for Acquias most strategic, complex, and high-value Accounts. Operating at the intersection of business strategy and technical architecture, this role
Company Overview KLA is a global leader in diversified electronics for the semiconductor manufacturing ecosystem. Virtually every electronic device in the world is produced using our technologies. No laptop, smartphone, wearable device, voice-controlled gadget, flexible screen,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)